Health ❯ Healthcare ❯ Vaccines

mRNA Technology

COVID-19 Vaccines Vaccine Development Pandemic Preparedness Public Health Cancer Treatment Flu Vaccines Cancer Vaccines Cancer Research COVID-19 Operation Warp Speed

FDA Staff Sees No Major Deficiencies in Moderna’s mFlusiva Application

A June 18 advisory committee vote sets up an August 5 FDA decision that could clear the first mRNA seasonal flu shot for U.S. adults.

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

Bundestag Covid Inquiry Grills Lauterbach and Wieler After AfD Witness Labels Vaccines a 'Human Experiment'

FDA to Review Moderna’s Flu Shot as Shares Rally on Earnings Beat

BioNTech’s Personalized mRNA Vaccine Shows Durable Immune Response in Triple-Negative Breast Cancer Phase 1

Moderna Opens UK’s First Onshore mRNA Vaccine Plant at Harwell

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

NHS Begins Phase II/III Trial of mRNA Vaccine for Head and Neck Cancer

RFK Jr. Pulls $500M From mRNA Vaccine Projects, Draws Sharp Criticism

HHS Pulls Funding From 22 mRNA Vaccine Programs

Germany Awards National Prize to Biontech Founders Sahin and Türeci

John Rich's Advice to Trump Shaped Vaccine Messaging Strategy

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet